In the 12 months to Nov 8, 2026, on the open market: sold $9.1M of VRTX. Filed a median of 2 business days after the trade.
Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these
Insider purchases above the line: $0Insider sales below: $9.1M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
VRTXSold: VERTEX PHARMACEUTICALS INC / MA Jun 26, 2026596 sharesfiled Jun 30, 202615,337 shares held directly after, as filed10b5-1 planfiling$288K
VRTXSold: VERTEX PHARMACEUTICALS INC / MA Jun 18, 20261,020 sharesfiled Jun 23, 202615,933 shares held directly after, as filed10b5-1 planfiling$471K
VRTXSold: VERTEX PHARMACEUTICALS INC / MA Jun 15, 20264,062 sharesfiled Jun 17, 202616,953 shares held directly after, as filed10b5-1 planfiling$1.8M
VRTXSold: VERTEX PHARMACEUTICALS INC / MA Jun 5, 20261,745 sharesfiled Jun 9, 202621,015 shares held directly after, as filed10b5-1 planfiling$785K
VRTXSold: VERTEX PHARMACEUTICALS INC / MA May 29, 20261,974 sharesfiled Jun 2, 202622,760 shares held directly after, as filed10b5-1 planfiling$888K
VRTXSold: VERTEX PHARMACEUTICALS INC / MA May 15, 20261,354 sharesfiled May 19, 202624,734 shares held directly after, as filed10b5-1 planfiling$614K
VRTXSold: VERTEX PHARMACEUTICALS INC / MA May 12, 20266,988 sharesfiled May 14, 202626,088 shares held directly after, as filed10b5-1 planfiling$3.1M
VRTXSold: VERTEX PHARMACEUTICALS INC / MA Mar 13, 20262,329 sharesfiled Mar 17, 202635,405 shares held directly after, as filed10b5-1 planfiling$1.1M
Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.
